Entrada Therapeutics | Financial Information

SEC Filings

SEC Filings
Filing date	Form	Description	Filing Group	View
Jan 18, 2022	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001104659-22-004980.pdf 0001104659-22-004980.rtf 0001104659-22-004980.xls
Jan 13, 2022	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001104659-22-004129.pdf 0001104659-22-004129.rtf 0001104659-22-004129.xls
Dec 29, 2021	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001104659-21-154295.pdf 0001104659-21-154295.rtf 0001104659-21-154295.xls
Dec 16, 2021	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	Other	View HTML 0001104659-21-150588.pdf 0001104659-21-150588.rtf 0001104659-21-150588.xls
Dec 16, 2021	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001415889-21-006039.pdf 0001415889-21-006039.rtf 0001415889-21-006039.xls